Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice

Table 2 Comparison of native T1 values between patients with myocardial disease or coronary artery disease and control group

Group	Mid LV short-axis native T 1 (ms)			Group	Septum native T1 (ms)
Group	Mean ± SD	95% CI	p-value	Group	Mean ± SD	95% CI	p-value
Amyloidosis (n = 11)	1426 ± 57	1392–1460	*< 0.001*	Amyloidosis (n = 11)	1441 ± 72	1393–1490	*< 0.001*
DCM (n = 157)	1341 ± 52	1333–1349	*< 0.001*	DCM (n = 157)	1349 ± 59	1340–1358	*< 0.001*
HCM (n = 112)	1333 ± 56	1323–1344	*< 0.001*	HCM (n = 112)	1345 ± 59	1334–1356	*< 0.001*
Myocarditis (n = 17)	1344 ± 62	1315–1374	*0.004*	Myocarditis (n = 17)	1355 ± 56	1327–1384	*0.002*
CAD (n = 293)	1316 ± 51	1310–1322	*< 0.001*	CAD (n = 247)	1328 ± 54	1321–1334	*< 0.001*
Control (n = 595)	1294 ± 37	1291–1297		Control (n = 638)	1304 ± 42	1301–1308

A p-value < 0.05 indicates statistical significance
SD standard deviation, CI confidence interval, DCM dilated cardiomyopathy, HCM hypertrophic cardiomyopathy, CAD coronary artery disease

ISSN: 1471-2261